UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Qualification | |
Date Qualified: | December 3, 2021 9:00 A.M. |
Form: | 1-A |
CIK: | 0001819663 |
Company Name: | Coeptis Therapeutics Inc. |
File Number: | 024-11719 |
- COEP Dashboard
- Financials
- Filings
- Insider
- Institutional
- Shorts
- News
-
QUALIF Filing
Coeptis Therapeutics (COEP) QUALIFNotice of qualification
Filed: 6 Dec 21, 12:15am